Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis

The lack of vaccine and limited antiviral options against respiratory syncytial virus (RSV) highlights the need for novel therapeutic strategies. One alternative is to develop drugs that target host factors required for viral replication. Several microarray and proteomics studies had been published...

Descripción completa

Detalles Bibliográficos
Autores principales: Dapat, Clyde, Oshitani, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819838/
https://www.ncbi.nlm.nih.gov/pubmed/26760927
http://dx.doi.org/10.1586/14787210.2016.1141676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819838/
https://www.ncbi.nlm.nih.gov/pubmed/26760927
http://dx.doi.org/10.1586/14787210.2016.1141676

Ejemplares similares